Table II.
Associations between miRNAs and clinical characteristics using data from The Cancer Genome Atlas data.
| hsa-miR-17-3p
|
hsa-miR-145-5p
|
hsa-miR-98-5p
|
|
|---|---|---|---|
| Clinical characteristics | P-value | P-value | P-value |
| Age (59.44±11.42) | 0.10 | 0.30 | 0.26 |
| Radiation therapy (yes/no) | 0.90 | 0.61 | 6.62×10−3 |
| Neoplasm subdivision (bilateral/left/right) | 0.95 | 0.09 | 0.30 |
| Stage (II/III/IV) | 0.01 | 0.01 | 0.39 |
| Lymphatic invasion (yes/no) | 0.53 | 0.65 | 0.12 |
| Histologic grade (G1-G2/G3-G4) | 0.26 | 0.85 | 0.88 |
| Recurrence (yes/no) | 0.14 | 0.74 | 0.09 |
hsa, homo sapiens; miRNA, microRNA. Data are presented as the mean ± standard deviation. The survival package was used for the statistical analysis.